Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Sodium Phosphate, Dibasic, Anhydrous; Sodium Phosphate, Monobasic, Monohydrate Patent Expiration

Sodium Phosphate, Dibasic, Anhydrous; Sodium Phosphate, Monobasic, Monohydrate is Used for bowel cleansing in preparation for colonoscopy in adults. It was first introduced by Salix Pharmaceuticals Inc in its drug Visicol on Sep 21, 2000. Another drug containing Sodium Phosphate, Dibasic, Anhydrous; Sodium Phosphate, Monobasic, Monohydrate is Osmoprep. 2 different companies have introduced drugs containing Sodium Phosphate, Dibasic, Anhydrous; Sodium Phosphate, Monobasic, Monohydrate.


Sodium Phosphate, Dibasic, Anhydrous; Sodium Phosphate, Monobasic, Monohydrate Patents

Given below is the list of patents protecting Sodium Phosphate, Dibasic, Anhydrous; Sodium Phosphate, Monobasic, Monohydrate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Osmoprep US7687075 Colonic purgative composition with soluble binding agent Jun 22, 2028 Salix Pharms
Osmoprep US5616346 Non-aqueous colonic purgative formulations May 18, 2013

(Expired)

 Salix Pharms
Visicol US5616346 Non-aqueous colonic purgative formulations May 18, 2013

(Expired)

 Salix Pharms



Sodium Phosphate, Dibasic, Anhydrous; Sodium Phosphate, Monobasic, Monohydrate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Sodium Phosphate, Dibasic, Anhydrous; Sodium Phosphate, Monobasic, Monohydrate Generic API Manufacturers

Only one generic application has been filed for Sodium Phosphate, Dibasic, Anhydrous; Sodium Phosphate, Monobasic, Monohydrate.

Given below is the list of companies who have filed for Sodium Phosphate, Dibasic, Anhydrous; Sodium Phosphate, Monobasic, Monohydrate generic, along with the locations of their manufacturing plants worldwide.


1. NOVEL LABS INC

Novel Laboratories Inc has filed for 1 generic for Sodium Phosphate, Dibasic, Anhydrous; Sodium Phosphate, Monobasic, Monohydrate. This 0.398gm;1.102gm version comes by the name MONOBASIC SODIUM PHOSPHATE AND DIBASIC SODIUM PHOSPHATE. Given below are the details of the strengths of this generic introduced by Novel Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.398GM; 1.102GM

(reference standard)

tablet Prescription ORAL N/A Dec 30, 2011